U.S. Hemostats Market is Expected to Grow at 7.4% CAGR in the Forecast Period of 2021 to 2028

The U.S. Hemostats Market is growing with an increased incidence of chronic diseases and awareness regarding hemostats. However, increasing product recall and the high cost of hemostats may obstruct the market's growth in the given forecast period.

U.S. Hemostats Market Scenario

The market leader in the U.S. hemostats market is Johnson & Johnson Services, Inc. which accounts for an estimated market share of approximately 21.79%. The company has gained outstanding sales through providing hemostats products and devices.

In December 2019, Johnson & Johnson Services, Inc. announced that they had launched VISTASEAL Fibrin Sealant (Human) to help surgeons manage bleeding during surgery which contains a combination of fibrinogen and thrombin, clotting proteins found in human plasma. This has increased company’s product pipeline

Trends Impacting the Market

The U.S. hemostats market is becoming more competitive with companies such as Johnson & Johnson Services, Inc., Baxter, and BD. They are the top dominating companies in the U.S. hemostats market, having a maximum number of products. Data Bridge Market Research's new reports highlight the major growth factors and opportunities in the U.S. hemostats market.

For more analysis on the U.S. hemostats market, request a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=us-hemostats-market

U.S. Hemostats Market Developments

In June 2020, BD announced that they had completed the acquisition of Straub Medical AG. This privately-held company develops and sells medical products and devices that treat peripheral arterial disease (PAD) and venous disease. This has increased company’s product portfolio

In March 2021, B. Braun Melsungen AG has announced that they had reconstituted its Supervisory Board with four new shareholders for its company. They resumed their work on the inaugural day session, thereby enhancing its product production and portfolio. This is expected to increase its revenue for the future market

Scope of the U.S. Hemostats Market

The U.S. hemostats market is categorized into five notable segments based on type, application, formulation, end users, and distribution channel. All country-based analysis of the U.S. hemostats market is further analyzed based on further segmentation.

On the basis of type, the U.S. hemostats market is segmented into combination agent hemostats, thrombin based hemostats, collagen based hemostats, oxidized regenerated cellulose based hemostats, and gelatine based hemostats. On the basis of formulation, the U.S. hemostats market is segmented into matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. On the basis of application, the U.S. hemostats market is segmented into wound closure and surgical hemostats. On the basis of end-users, the U.S. hemostats market is segmented into hospitals, community healthcare, ambulatory centres, clinics, and others. On the basis of distribution channel, the U.S. hemostats market is segmented into direct tender and third party distributors

To know more about the study https://www.databridgemarketresearch.com/reports/us-hemostats-market

Key Pointers Covered in U.S. Hemostats Market Industry Trends and Forecast to 2028

Market Size

Top to Bottom Market Analysis

Recent Developments for Market Competitors

Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

Baxter

B. Braun Melsungen AG

Teleflex Incorporated

Pfizer Inc.

Arch Therapeutics, Inc.

Biom’Up

Hemostatis LLC

CyroLife Inc.

3-D Matrix, Ltd.

Integra LifeSciences

L&R Group

Marine Polymer Technologies, Inc.

Medtrade Products Limited

Meril Life Science Pvt. Ltd.

RESORBA Medical GmbH

Starch Medical, Inc.

Stryker

Unilene

Johnson & Johnson Services, Inc.

Above are the key players covered in the report, to know about more and exhaustive list of Hemostats Market companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=us-hemostats-market

Research Methodology: U.S. Hemostats Market.

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.

The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Pharmacists, Hospitals, Clinicians and Technicians, Academic Professionals and Researchers

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers, among others.

Related Reports